Latest Period
n/a
Security Snapshot
Latigo Biotherapeutics, Inc. - Common stock, par value $0.0001 per share Institutional Ownership
CUSIP: 517954103
13F Institutional Holders and Ownership History
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, par value $0.0001 per share
- Shares outstanding
- 63,703,540
Key facts
- 517954103 - Latigo Biotherapeutics, Inc. - Common stock, par value $0.0001 per share is tracked under CUSIP 517954103.
- Latest finished 13F holder period is not available.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Quarterly ownership records are not available yet for this CUSIP.
- This page updates as SEC-backed holdings history becomes available.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
517954103
Latest holder period
n/a
13F holders
13D/G owners
4
CIK / CUSIP context first
517954103 full holder history
Latigo Biotherapeutics, Inc. SEC filings
Latigo Biotherapeutics, Inc. insider transactions
Broader feeds
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
517954103
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Foresite Capital Fund VI LP | 14% | 9,181,328 | James B. Tananbaum | 10 Aug 2026 | ||||
| RA CAPITAL MANAGEMENT, L.P. | 8.4% | 5,295,690 | RA Capital Management, L.P. | 10 Aug 2026 | ||||
| Deep Track Capital, LP | 7% | 4,446,656 | Deep Track Capital, LP | 07 Aug 2026 | ||||
| AI Biotechnology LLC | 5% | 3,185,177 | AI Biotechnology LLC | 11 Aug 2026 |